about
Pandemic influenza a (2009 H1N1) in human immunodeficiency virus-infected catalan children.Confirmation of gestational exposure to alprazolam by analysis of biological matrices in a newborn with neonatal sepsis.[Pregnancy as an opportunity to diagnose human-immunodeficiency virus immigrant women in Catalonia].Dynamics of the NK-cell subset redistribution induced by cytomegalovirus infection in preterm infants.Safety and antiviral response at 12 months of lopinavir/ritonavir therapy in human immunodeficiency virus-1-infected children experienced with three classes of antiretrovirals.Human immunodeficiency virus infection in pregnant women, transmission and zidovudine therapy.MHC class II alleles associated with clinical and immunological manifestations of HIV-1 infection among children in Catalonia, Spain.Older children and adolescents surviving with vertically acquired HIV infection.A parallel study of different array-CGH platforms in a set of Spanish patients with developmental delay and intellectual disability.[Recommendations of the CEVIHP/SEIP/AEP/PNS on antiretroviral treatment in HIV-infected children and teenagers].A170P mutation in SHOX gene in a patient not presenting with Madelung deformity.Efficient application of next-generation sequencing for the diagnosis of rare genetic syndromesNeonatal Withdrawal Syndrome After Chronic Maternal Drinking of MateAreca-Nut Abuse and Neonatal Withdrawal SyndromeVertical transmission of HIVQT interval in newborns of different ethnic origin: usefulness of neonatal ECG screeningA prospective evaluation of neonatal hypoglycaemia in infants of women with gestational diabetes mellitus
P50
Q30393123-0E689F9D-B89D-42C7-8DD9-90DDFF87D0ECQ34622095-76C23ECB-4F69-4D79-887A-09245C5C12C6Q40546264-79C4B394-F5E6-42D2-ACA2-A159CECFF0FBQ41513024-081043CB-5A25-4BFD-B94C-FDBBB0C28E0FQ42670445-4D720A65-D503-4A6B-8D29-860DAF71FDA6Q45736662-77AB6F42-E433-4233-B9C7-89FF6C0BA3ACQ46737123-8E40678B-7AD4-49F8-8C04-4E51CBB6A05CQ47615049-E773FB35-D665-4956-9FBB-B0630D72B535Q50752164-361DF0D0-F597-46AA-B068-5DF636A2BCD6Q53856679-2A0893FF-F32C-4619-A9D4-4A1E0612750FQ54316807-11F0884F-D982-4BFF-B979-3FD95B70ABE5Q58050328-5FF19BE8-CBCE-4011-81F8-62855E016CD3Q60586216-E33AD1D4-3519-4760-8AB7-E2700F2D2140Q60586222-DB9FAA0B-A79F-40AF-897B-D98BB765803CQ68323317-394EE8D2-55D6-4885-8966-BEDE103A23E7Q81936926-3E6FFAA9-C6EB-41C1-BAE8-0D36B42F8B7FQ84003454-75433198-CB90-4ADB-B6D1-E19AA99ED688
P50
description
onderzoeker
@nl
researcher, ORCID id # 0000-0003-4119-4510
@en
name
Antonio Mur
@ast
Antonio Mur
@en
Antonio Mur
@es
Antonio Mur
@nl
type
label
Antonio Mur
@ast
Antonio Mur
@en
Antonio Mur
@es
Antonio Mur
@nl
prefLabel
Antonio Mur
@ast
Antonio Mur
@en
Antonio Mur
@es
Antonio Mur
@nl
P106
P1153
6603764650
P21
P31
P496
0000-0003-4119-4510